公告
Date |
Announcement |
|---|---|
| September 16, 2021 |
Repligen Announces Agreement to Acquire Avitide Inc. Read More |
| September 9, 2021 |
Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies |
|
September 3, 2021 |
Repligen Extends Long Term Supply Agreement with Cytiva for Affinity Ligands. Read More |
|
2021年6月22日 |
Repligen Corporation Announces Agreement to Acquire Polymem S.A. Read More |
|
February 8, 2021 |
Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines. Read More |
|
2020年10月27日 |
Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions. Read More |
| 2020年10月1日 |
Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 Vaccines. Read More |
|
2020年6月29日 |
Repligen Announces Agreement to Acquire Engineered Molding Technology. Read More |
|
2019年4月4日 |
Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator C Technologies. Read More |
|
Septermber 4, 2018 |
Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors. Read More |
|
2018年6月28日 |
Repligen选择Purolite Life Sciences作为新型高性能配基商业化合作伙伴。 阅读全文 |
|
2018年6月27日 |
Repligen宣布与Navigo Proteins达成下一代亲和配基独家合作开发协议。 阅读全文 |
|
2017年6月23日 |
Repligen Corporation与 Spectrum Inc. 宣布合并。 阅读全文 |
|
2016年12月15日 |
Repligen acquires TangenX Technology Corporation. Read More |
|
2016年10月4日 |
Repligen Launches Single-Use XCell™ ATF System for Bioprocess Intensification. Read More |
|
2016年4月4日 |
Repligen 收购 Atoll GmbH。 阅读全文 |
最新动态
新闻联系方式
Sondra Newman
高级总监，投资者关系
电话：781.250.0111
免费电话：800.622.2259
传真：781.250.0115